Overall market sentiment has been neutral on Vaccinex Inc (VCNX) stock lately. VCNX receives a Neutral rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With VCNX Stock Today?
Vaccinex Inc (VCNX) stock is trading at $8.22 as of 10:04 AM on Friday, Feb 19, an increase of $5.35, or 186.41% from the previous closing price of $2.87. The stock has traded between $5.80 and $9.56 so far today. Volume today is high. So far 94,088,941 shares have traded compared to average volume of 732,632 shares.
To see InvestorsObserver's Sentiment Score for Vaccinex Inc click here.
More About Vaccinex Inc
Vaccinex Inc is a clinical-stage biotechnology company. It is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. The company's product pipeline includes pepinemab (VX15) Neurology, VX5 Autoimmune, and others.
Click Here to get the full Stock Score Report on Vaccinex Inc (VCNX) Stock.
